Fetal DNA testing is a non-invasive prenatal test (NIPT) that analyzes cell-free fetal DNA (cffDNA) found in the mother’s blood. It is generally used to detect chromosomal abnormalities in the developing fetus, such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).
The test is typically performed between 10 and 20 weeks of pregnancy and involves a simple blood draw from the mother. The cffDNA is then extracted from the collected blood sample and analyzed in a laboratory using advanced sequencing technology.
Fetal DNA testing has a high accuracy rate of over 99% and is considered a reliable alternative to invasive procedures, such as amniocentesis or chorionic villus sampling, which carry a small risk of miscarriage.
It is important to note that fetal DNA testing does not identify all genetic disorders or birth defects and is not a diagnostic test. If a result comes back indicating a potential problem, further testing through amniocentesis or chorionic villus sampling may be recommended to confirm the diagnosis.
Overall, fetal DNA testing provides expectant parents with important information about their developing baby and can help them make informed decisions about their pregnancy and prepare for the future.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page